Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
about
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapyTreatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studiesThe cell surface mucin podocalyxin regulates collective breast tumor budding.PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.A comparative study of two PODXL antibodies in 840 colorectal cancer patients.The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancerPrognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.Podocalyxin as a Prognostic Marker in Gastric CancerExpression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis.Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancerPodocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability.Effect of ageing and single nucleotide polymorphisms associated with the risk of aggressive prostate cancer in a New Zealand population.Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancer"Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signaling
P2860
Q21146638-56043D86-6707-41F6-BE4D-8F864B445B91Q26775541-B23BF2F5-123A-4F8F-B510-6159992E6E04Q27338644-2D208D30-10F6-4F57-9395-2B0B52986872Q33600992-1DF94A85-72B4-4A22-8582-43DB7BE269B0Q33726716-DC0D8EC7-7EC1-4052-85D3-CD3871284DB4Q33938468-399B3ACA-FFC5-4AF9-BD4C-F4075CA992A6Q35214846-280509C6-AD4E-45EA-A72E-E3A51F7AF3BFQ35647464-9C00DE7F-D576-467C-A164-A2D94922C743Q35656610-81F7EFFE-AC11-4AFB-89BC-9404B4AFBB86Q35870705-D4148F56-2E15-4691-AAC3-9D29976B1A4EQ36091414-BEB1779F-C7C4-4975-AB27-83D9D7906487Q36236781-FACE2241-62AE-49CB-8BE2-4F41546517CBQ36886612-B1B30C9D-17E4-4958-8AA7-2CFBC08DC18BQ37114865-7A20D4E2-5658-4EF3-A5AB-2B5D823C922CQ37191712-8DFCF5EF-D83F-4F76-BDF7-CB7CF3824303Q37697790-BAEE9677-1497-469B-AB2C-6DA2F569376FQ37735632-94289599-D577-4246-9B7F-29D1011EF179Q38259585-C693F614-D260-4B4F-A63D-3972C33427D6Q40311743-B122D41A-230E-4F61-9970-1824A2F1D4C0Q47860795-2091D256-5A81-4960-A223-A1B646E3D257Q51804729-2235707D-A41A-42DA-9703-9A489EF36565Q57112164-6CD72007-8BC1-445D-8C45-175634CE8B0FQ58727488-81C70FA3-5E83-4619-8A03-26CDEACED931
P2860
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Membranous expression of podoc ...... in urothelial bladder cancer.
@en
type
label
Membranous expression of podoc ...... in urothelial bladder cancer.
@en
prefLabel
Membranous expression of podoc ...... in urothelial bladder cancer.
@en
P2093
P2860
P356
P1476
Membranous expression of podoc ...... in urothelial bladder cancer.
@en
P2093
A H Larsson
H Johannesson
J Eberhard
P-U Malmström
U Segersten
P2860
P2888
P304
P356
10.1038/BJC.2013.215
P407
P577
2013-05-07T00:00:00Z